{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:18:13Z","timestamp":1770538693390,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40123-025-01263-3","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:22:19Z","timestamp":1762482139000},"page":"193-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Photobiomodulation Therapy with Low-Level Light in Chronic Central Serous Chorioretinopathy: A Pilot Study"],"prefix":"10.1007","volume":"15","author":[{"given":"Claudio","family":"Iovino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba Chiara","family":"Termite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Boscia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Sannace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Boscia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Giannaccare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-967X","authenticated-orcid":false,"given":"Pasquale","family":"Viggiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"1","key":"1263_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40942-023-00443-2","volume":"9","author":"A Zarnegar","year":"2023","unstructured":"Zarnegar A, Ong J, Matsyaraja T, Arora S, Chhablani J. Pathomechanisms in central serous chorioretinopathy: a recent update. Int J Retina Vitreous. 2023;9(1):3.","journal-title":"Int J Retina Vitreous"},{"issue":"2","key":"1263_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2500\/aap.2015.36.3827","volume":"36","author":"PA Ricketti","year":"2015","unstructured":"Ricketti PA, Unkle DW, Cleri DJ, et\u00a0al. Central serous chorioretinopathy secondary to corticosteroids in patients with atopic disease. Allergy Asthma Proc. 2015;36(2):123\u20139.","journal-title":"Allergy Asthma Proc"},{"key":"1263_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000324599","volume":"46","author":"ACT Fok","year":"2011","unstructured":"Fok ACT, Chan PPM, Lam DSC, Lai TYY. Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy. Ophthalmic Res. 2011;46:160\u20133.","journal-title":"Ophthalmic Res"},{"key":"1263_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41433-022-02044-z","volume":"37","author":"NK Sahoo","year":"2023","unstructured":"Sahoo NK, Ong J, Selvam A, et\u00a0al. Longitudinal follow-up and outcome analysis in central serous chorioretinopathy. Eye (Lond). 2023;37:732\u20138.","journal-title":"Eye (Lond)"},{"key":"1263_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40662-023-00349-y","volume":"10","author":"X Zhang","year":"2023","unstructured":"Zhang X, Lim CZF, Chhablani J, et\u00a0al. Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies. Eye Vis. 2023;10:33.","journal-title":"Eye Vis"},{"issue":"11","key":"1263_CR6","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1136\/bjophthalmol-2018-313048","volume":"103","author":"NK Sahoo","year":"2019","unstructured":"Sahoo NK, Mishra SB, Iovino C, et\u00a0al. Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy. Br J Ophthalmol. 2019;103(11):1615\u20138.","journal-title":"Br J Ophthalmol"},{"key":"1263_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.07.003","volume":"73","author":"TJ van Rijssen","year":"2019","unstructured":"van Rijssen TJ, van Dijk EHC, Yzer S, et\u00a0al. Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res. 2019;73:100770.","journal-title":"Prog Retin Eye Res"},{"key":"1263_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101236","author":"HMA Feenstra","year":"2024","unstructured":"Feenstra HMA, van Dijk EHC, Cheung CMG, et\u00a0al. Central serous chorioretinopathy: an evidence-based treatment guideline. Prog Retin Eye Res. 2024. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101236.","journal-title":"Prog Retin Eye Res"},{"key":"1263_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40942-025-00660-x","volume":"11","author":"H Getahun","year":"2025","unstructured":"Getahun H, Apte RS. Therapeutic interventions for chronic central serous chorioretinopathy: a comprehensive assessment of systematic reviews. Int J Retin Vitreous. 2025;11:34.","journal-title":"Int J Retin Vitreous"},{"issue":"6","key":"1263_CR10","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41433-022-02091-6","volume":"37","author":"L Toto","year":"2023","unstructured":"Toto L, Ruggeri ML, Evangelista F, et\u00a0al. Choroidal modifications assessed by means of choroidal vascularity index after oral eplerenone treatment in chronic central serous chorioretinopathy. Eye (Lond). 2023;37(6):1214\u20138.","journal-title":"Eye (Lond)"},{"issue":"1","key":"1263_CR11","first-page":"11","volume":"248","author":"FM van den Tillaart","year":"2025","unstructured":"van den Tillaart FM, Hartgers F, Hoyng CB, Yzer S. Dealing with the verteporfin shortage: treatment options and outcomes in patients with chronic and non-resolving central serous chorioretinopathy. Ophthalmologica. 2025;248(1):11\u201321.","journal-title":"Ophthalmologica"},{"key":"1263_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1109\/JSTQE.2016.2561201","volume":"22","author":"LF de Freitas","year":"2016","unstructured":"de Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron. 2016;22:348\u201364.","journal-title":"IEEE J Sel Top Quantum Electron"},{"key":"1263_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9061724","volume":"9","author":"C Dompe","year":"2020","unstructured":"Dompe C, Moncrieff L, Matys J, et\u00a0al. Photobiomodulation\u2014Underlying mechanism and clinical applications. J Clin Med. 2020;9:1\u201317.","journal-title":"J Clin Med"},{"key":"1263_CR14","first-page":"208","volume":"2","author":"FD Marco","year":"2013","unstructured":"Marco FD, Romeo S, Nandasena C, Purushothuman S, et\u00a0al. The time course of action of two neuroprotectants, dietary saffron and photobiomodulation, assessed in the rat retina. Am J Neurodegener Dis. 2013;2:208\u201320.","journal-title":"Am J Neurodegener Dis"},{"key":"1263_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057828","volume":"8","author":"R Begum","year":"2013","unstructured":"Begum R, Powner MB, Hudson N, Hogg C, Jeffery G. Treatment with 670 nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age-related macular degeneration model. PLoS\u00a0One. 2013;8:e57828.","journal-title":"PLoS\u00a0One"},{"key":"1263_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14070886","author":"T-W Chen","year":"2025","unstructured":"Chen T-W, Wen Y-T, Liu P-K, Hossen M, Tsai R-K. Roles of 670 nm photobiomodulation on rat anterior ischemic optic neuropathy: enhancing RGC survival, mitochondrial function, and anti-inflammatory response. Antioxidants. 2025. https:\/\/doi.org\/10.3390\/antiox14070886.","journal-title":"Antioxidants"},{"issue":"5","key":"1263_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/ICU.0000000000001154","volume":"36","author":"NRX Tan","year":"2025","unstructured":"Tan NRX, Chan KE, Lim BXH, et\u00a0al. Photobiomodulation: evidence and applications in ophthalmology. Curr Opin Ophthalmol. 2025;36(5):345\u201381.","journal-title":"Curr Opin Ophthalmol"},{"key":"1263_CR18","doi-asserted-by":"crossref","unstructured":"Iovino C, Damiano L, Piccirillo V, Testa F, Giannaccare G, Simonelli F. Photobiomodulation therapy for serous pigment epithelium detachment in chronic central serous Chorioretinopathy. Retin Cases Brief Rep. 2024.","DOI":"10.1097\/ICB.0000000000001665"},{"key":"1263_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2025.101372","volume":"107","author":"P Viggiano","year":"2025","unstructured":"Viggiano P, Boscia G, Sadeghi E, et\u00a0al. Pachychoroid disease spectrum: how multimodal imaging and OCT angiography have improved our knowledge. Prog Retin Eye Res. 2025;107:101372.","journal-title":"Prog Retin Eye Res"},{"key":"1263_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ajo.2025.04.005","volume":"276","author":"P Viggiano","year":"2025","unstructured":"Viggiano P, Moscara F, Termite AC, et\u00a0al. Choroidal layer analysis under flat irregular pigment epithelial detachments in central serous chorioretinopathy. Am J Ophthalmol. 2025;276:210\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1263_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40123-018-0121-2","volume":"7","author":"I Zucchiatti","year":"2018","unstructured":"Zucchiatti I, Sacconi R, Parravano MC, et\u00a0al. Eplerenone versus observation in the treatment of acute central serous chorioretinopathy: a retrospective controlled study. Ophthalmol Ther. 2018;7(1):109\u201318.","journal-title":"Ophthalmol Ther"},{"issue":"10220","key":"1263_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(19)32981-2","volume":"395","author":"A Lotery","year":"2020","unstructured":"Lotery A, Sivaprasad S, O\u2019Connell A, et\u00a0al. Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10220):294\u2013303.","journal-title":"Lancet"},{"issue":"6","key":"1263_CR23","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1007\/s40123-023-00816-8","volume":"12","author":"P Viggiano","year":"2023","unstructured":"Viggiano P, Boscia G, Borrelli E, et\u00a0al. Choriocapillaris reperfusion in resolved chronic central serous chorioretinopathy treated with eplerenone: long-term effects on the fellow eye. Ophthalmol Ther. 2023;12(6):3199\u2013210.","journal-title":"Ophthalmol Ther"},{"issue":"17","key":"1263_CR24","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.2147\/OPTH.S411094","volume":"17","author":"G Boscia","year":"2023","unstructured":"Boscia G, Viggiano P, Marzulli F, et\u00a0al. Continuous eplerenone treatment in chronic central serous chorioretinopathy: long-term results from a pilot study. Clin Ophthalmol. 2023;17(17):2003\u201312.","journal-title":"Clin Ophthalmol"},{"key":"1263_CR25","doi-asserted-by":"crossref","unstructured":"Viggiano P, Boscia G, Clemente A, e al. Photobiomodulation-induced choriocapillaris perfusion enhancement and outer retinal remodelling in intermediate age-related macular degeneration: a promising therapeutic approach with short-term results. Eye (Lond). 2025;39(10):2057\u20132063","DOI":"10.1038\/s41433-025-03805-2"},{"issue":"11","key":"1263_CR26","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1007\/s40123-024-01030-w","volume":"13","author":"E Borrelli","year":"2024","unstructured":"Borrelli E, Coco G, Pellegrini M, et\u00a0al. Safety, tolerability, and short-term efficacy of low-level light therapy for dry age-related macular degeneration. Ophthalmol Ther. 2024;13(11):2855\u201368.","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"1263_CR27","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12886-024-03711-3","volume":"24","author":"C Iovino","year":"2024","unstructured":"Iovino C, Iodice CM, Damiano L, et\u00a0al. Fluorescein angiography patterns and subretinal hyperreflective material predict subthreshold micropulse laser response in chronic central serous chorioretinopathy. BMC Ophthalmol. 2024;24(1):478.","journal-title":"BMC Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01263-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01263-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01263-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:32:41Z","timestamp":1770453161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01263-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1263"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01263-3","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Giuseppe Giannaccare has received speaker honoraria from Espansione Marketing. Claudio Iovino, Carmela Sannace, and Pasquale Viggiano have received equipment loans of eye-light\n                      \u00ae\n                      system. The other authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was performed in accordance with the 1964 Declaration of Helsinki and its later amendments. As per Italian regulations for retrospective studies, formal approval from an ethics committee was not required, but the institutional ethics committee was informed about the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}